Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs
Elliott Richelson
Neuroscience
Research output
:
Contribution to journal
›
Review article
›
peer-review
129
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacokinetic drug interactions of new antidepressants: A review of the effects on the metabolism of other drugs'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Metabolic Side Effects of Drugs and Substances
100%
Drug Interactions
59%
Antidepressive Agents
54%
Pharmacokinetics
45%
Serotonin Uptake Inhibitors
26%
Pharmaceutical Preparations
25%
Isoenzymes
24%
nefazodone
19%
Cytochrome P-450 Enzyme Inhibitors
19%
Mirtazapine
17%
Fluvoxamine
16%
Serotonin and Noradrenaline Reuptake Inhibitors
16%
Venlafaxine Hydrochloride
16%
Cytochrome P-450 CYP2C9
16%
Cytochrome P-450 CYP2C19
16%
Sertraline
15%
Cytochrome P-450 CYP1A2
15%
Serotonin Antagonists
15%
Paroxetine
15%
Cytochrome P-450 CYP2D6
15%
Fluoxetine
14%
Cytochrome P-450 CYP3A
13%
Obsessive-Compulsive Disorder
13%
Psychological Inhibition
9%
Protein Isoforms
9%
Elderly
8%
Liver
6%